CEFIXIME (Suprax®)
Clinical Indication
For the management of irinotecan induced diarrhoea in paediatric patients, not responsive to standard treatments.
Date of classification
June 2023
Red
Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.